NADAQ: EGRX Investor Notice: Lawsuit Alleges Securities Laws Violations by Eagle Pharmaceuticals, Inc.
An investor, who purchased shares of Eagle Pharmaceuticals, Inc. (NADAQ: EGRX), filed a lawsuit against Eagle Pharmaceuticals, Inc. over alleged violations of Federal Securities Laws.
View full press release